Circulating CD14++CD16+monocyte subsets as a surrogate marker of inflammatory activity in patients with cardiac sarcoidosis

被引:0
|
作者
Orii, M. [1 ]
Imanishi, T. [1 ]
Teraguchi, I. [1 ]
Nishiguchi, T. [1 ]
Ozaki, Y. [1 ]
Hirata, K. [1 ]
Kubo, T. [1 ]
Tanaka, A. [1 ]
Akasaka, T. [1 ]
机构
[1] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P5616
引用
收藏
页码:1015 / 1016
页数:2
相关论文
共 50 条
  • [11] The imbalance of circulating monocyte subgroups with a higher proportion of the CD14+CD16+CD163+phenotype in patients with preeclampsia
    Gong, Fengyan
    Wang, Junwei
    Lu, Nianhong
    Wang, Jiangyuan
    Wang, Jia
    Shi, Xu
    Cui, Miao
    Cui, Lifeng
    IMMUNOLOGY LETTERS, 2023, 253 : 1 - 7
  • [12] Circulating Inflammatory Monocytes (CD14+CD16+) Are Elevated in Severe Obesity
    Coen, Paul M.
    Goodpaster, Bret H.
    DIABETES, 2010, 59 : A356 - A356
  • [13] Changes in Circulating Monocyte Subsets (CD16 Expression) and Neutrophil-to-Lymphocyte Ratio Observed in Patients Undergoing Cardiac Surgery
    Gawdat, Kareem
    Legere, Stephanie
    Wong, Chloe
    Myers, Tanya
    Marshall, Jean Sylvia
    Hassan, Ansar
    Brunt, Keith R.
    Kienesberger, Petra C.
    Pulinilkunnil, Thomas
    Legare, Jean-Francois
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2017, 4
  • [14] Prediction of outcome using CD14++CD16−, CD14++CD16+ and CD14+CD16++ monocyte subpopulations in patients with complicated intra-abdominal infections
    Evgeni Dimitrov
    Krasimira Halacheva
    Georgi Minkov
    Emil Enchev
    Yovcho Yovtchev
    Medical Microbiology and Immunology, 2023, 212 : 381 - 390
  • [15] Prediction of outcome using CD14++CD16-, CD14++CD16+ and CD14+CD16++ monocyte subpopulations in patients with complicated intra-abdominal infections
    Dimitrov, Evgeni
    Halacheva, Krasimira
    Minkov, Georgi
    Enchev, Emil
    Yovtchev, Yovcho
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2023, 212 (5) : 381 - 390
  • [16] Circulating CD14+CD16+monocyte levels predict tissue invasive character of cholangiocarcinoma
    Subimerb, C.
    Pinlaor, S.
    Lulitanond, V.
    Khuntikeo, N.
    Okada, S.
    McGrath, M. S.
    Wongkham, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 161 (03): : 471 - 479
  • [17] Expansion and differentiation of CD14+ CD16 and CD14++ CD16+ human monocyte subsets from cord blood CD34+ hematopoietic progenitors
    Stec, Malgorzata
    Weglarczyk, Kazimierz
    Baran, Jaroslaw
    Zuba, Ewa
    Mytar, Bozenna
    Pryjma, Juliusz
    Zembala, Marek
    JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 82 (03) : 594 - 602
  • [18] Human CD16+ and CD16- monocyte subsets display unique effector properties in inflammatory conditions in vivo
    Aguilar-Ruiz, Sergio R.
    Torres-Aguilar, Honorio
    Gonzalez-Dominguez, Erika
    Narvaez, Juana
    Gonzalez-Perez, Gabriela
    Vargas-Ayala, German
    Meraz-Rios, Marco A.
    Garcia-Zepeda, Eduardo A.
    Sanchez-Torres, Carmen
    JOURNAL OF LEUKOCYTE BIOLOGY, 2011, 90 (06) : 1119 - 1131
  • [19] SERUM LEVELS OF SOLUBLE CD163 AS A USEFUL MARKER OF MACROPHAGE/MONOCYTE ACTIVITY IN SARCOIDOSIS PATIENTS
    Tanimura, Hirotsugu
    Mizuno, Kana
    Okamoto, Hiroyuki
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2015, 32 (02) : 99 - 105
  • [20] CD14CD16 monocyte subset levels in heart failure patients
    Barisione, Chiara
    Garibaldi, Silvano
    Ghigliotti, Giorgio
    Fabbi, Patrizia
    Altieri, Paola
    Casale, Maria Carla
    Spallarossa, Paolo
    Bertero, Giovanni
    Balbi, Manrico
    Corsiglia, Luca
    Brunelli, Claudio
    DISEASE MARKERS, 2010, 28 (02) : 115 - 124